Skip to main content
Veterinary Medicines

Bovitubal - 28 000 inj. ad us vet. šķīdums injekcijām liellopiem, aitām, kazām, cūkām, zirgiem un suņiem

Authorised
  • Mycobacterium bovis, strain AN5, bovine tuberculin purified protein derivative

Product identification

Medicine name:
Bovitubal - 28 000 inj. ad us vet. šķīdums injekcijām liellopiem, aitām, kazām, cūkām, zirgiem un suņiem
Active substance:
  • Mycobacterium bovis, strain AN5, bovine tuberculin purified protein derivative
Target species:
  • Cattle
  • Dog
  • Sheep
  • Goat
  • Pig
  • Horse
Route of administration:
  • Intradermal use

Product details

Active substance and strength:
  • Mycobacterium bovis, strain AN5, bovine tuberculin purified protein derivative
    28000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intradermal use
    • Cattle
      • Not specified
        0
        day
    • Dog
    • Sheep
      • Not specified
        0
        day
    • Goat
      • Not specified
        0
        day
    • Pig
      • Not specified
        0
        day
    • Horse
      • Not specified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV04CF01
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/96/0180
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 8/01/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 8/01/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 8/01/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."